Dawn Carter Bir, Chief Commercial Officer at REATA PHARMACEUTICALS INC (RETA), sold 4,332 shares at $88.25 ($382K) on 2023-03-03, disclosed to the SEC on 2023-03-06.
Open-market sale of $382k RETA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.25 | 2,166 | $191K | 50.0% |
| 2 | $88.25 | 2,166 | $191K | 50.0% |
| Total | $88.25 avg | 4,332 | $382K | 100% |
| Filing → |
| RETA | SELL | 2023-05-17 | $186K | — | Filing → |
| RETA | SELL | 2023-03-15 | $1.6M | — | Filing → |
| RETA | SELL | 2023-03-08 | $17.0M | — | Filing → |